Home|Journals|Articles by Year Follow on Twitter

Directory for Medical Articles
 

Open Access

Research Article

JCR. 2020; 7(18): 4448-4455


IN-VITRO ANTI-OXIDANT AND ANTI-DIABETIC POTENTIAL OF METHANOLIC EXTRACT OF AGARICUS BISPORUS (WHITE BUTTON) AND COPRINUS COMATUS (SHAGGY MAN)

Jan Baz Khan, Abdur Rahim Khan, Dr. Muhammad Fiaz, Dr. Rahmat Ali Khan, Dr. Zainul Wahab, Dr. Muhammad Wasim Jan Khan, Inam Khan.

Abstract
Diabetes mellitus is considered, the sixth main cause of death throughout the world, and every
ten seconds a person dies from causes related to diabetes, mainly due to cardiovascular
complications. Mushrooms have been used for traditional foods and medicines globally. The
current study was tried to evaluate the in-vitro anti-oxidant and antidiabetic properties of
methanolic extracts of the Agaricus biosporus and coprinus comatus using alpha (α)-amylase,
beta (β)-glucosidase assays and anti-oxidant efficacy by applying ABTS and DPPH radical
scavenging assays. The Agaricus biosporus methanolic extracts (ABME) showed significant
inhibitory effects of DPPH (0.48 0.002) and ABTS (0.11 0.01) and C.comatus DPPH
(2.500.12) ABT (3.161.4) with an IC50 value respectively as compare with standard drug
ascorbic acid. The selected mushrooms species methanolic extracts exhibited significant
inhibitory activities of β-glucosidase and α-amylase having IC50 value at a concentration of
0.75μg , 0.80μg extracts in the same way as compared with the standard drug Glucophage. Our
results suggest that the Agaricus biosporus and coprinus comatus mushroom could be useful for
the control of diabetes and free radicals produced by different metabolic activities in our body.

Key words: Medicinal mushrooms, C. comatus, A. bisporus, α-amylase, β-glucosidase, DPPH, ABTS, anti-oxidanti, anti-diabetic potential.



Similar Articles

Growth differentiation factor 5: a neurotrophic factor with neuroprotective potential in Parkinson's disease.
Goulding SR, Anantha J, Collins LM, Sullivan AM, O'Keeffe GW
Neural regeneration research. 2022; 17(1): 38-44

Exosome treatment for stroke with diabetic comorbidity.
Venkat P, Chopp M
Neural regeneration research. 2022; 17(2): 315-317

Effects of selenium-containing compounds on Cu/Zn-induced neuronal cell death and potential application as therapeutic agents for neurological diseases.
Tanaka KI, Shimoda M, Kawahara M
Neural regeneration research. 2022; 17(2): 311-312

SYNGR4 and PLEKHB1 deregulation in motor neurons of amyotrophic lateral sclerosis models: potential contributions to pathobiology.
Marques RF, Duncan KE
Neural regeneration research. 2022; 17(2): 266-270

Diabetic retinopathy: neurovascular disease requiring neuroprotective and regenerative therapies.
Oshitari T
Neural regeneration research. 2022; 17(4): 795-796


Full-text options


Latest Statistics about COVID-19
• pubstat.org


Add your Article(s) to Indexes
• citeindex.org






Covid-19 Trends and Statistics
ScopeMed.com
CiteIndex.org
CancerLine
FoodsLine
PhytoMedline
Follow ScopeMed on Twitter
Author Tools
eJPort Journal Hosting
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
ScopeMed is a Database Service for Scientific Publications. Copyright ScopeMed Information Services.



ScopeMed Web Sites